This information is current as Erythematosus Human and Murine Systemic Lupus Bone Marrow Alters B Cell Development in Neutrophil-Mediated IFN Activation in the

[1]  J. Hodgin,et al.  Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. , 2013, The Journal of clinical investigation.

[2]  J. Knight,et al.  Lupus neutrophils: ‘NET’ gain in understanding lupus pathogenesis , 2012, Current opinion in rheumatology.

[3]  K. Krause,et al.  Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow. , 2011, Blood.

[4]  Matthias Kretzler,et al.  Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus , 2011, The Journal of Immunology.

[5]  Tomoki Ito,et al.  Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA–Peptide Complexes in Systemic Lupus Erythematosus , 2011, Science Translational Medicine.

[6]  J. Connolly,et al.  Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus , 2011, Science Translational Medicine.

[7]  M. Urowitz,et al.  SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation , 2011, Lupus.

[8]  M. Kehry,et al.  Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus. , 2010, Arthritis and rheumatism.

[9]  W. Mccune,et al.  A Distinct Subset of Proinflammatory Neutrophils Isolated from Patients with Systemic Lupus Erythematosus Induces Vascular Damage and Synthesizes Type I IFNs , 2010, The Journal of Immunology.

[10]  J. Anolik,et al.  B-cell biology and related therapies in systemic lupus erythematosus. , 2010, Rheumatic diseases clinics of North America.

[11]  S. Crampton,et al.  Innate pathways to B‐cell activation and tolerance , 2010, Annals of the New York Academy of Sciences.

[12]  P. Gregersen,et al.  Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study. , 2009, Arthritis and rheumatism.

[13]  I. Sanz,et al.  Novel Human Transitional B Cell Populations Revealed by B Cell Depletion Therapy1 , 2009, The Journal of Immunology.

[14]  I. Sanz,et al.  Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets , 2009, Immunologic research.

[15]  N. Knowlton,et al.  Gene expression in systemic lupus erythematosus: bone marrow analysis differentiates active from inactive disease and reveals apoptosis and granulopoiesis signatures. , 2008, Arthritis and rheumatism.

[16]  M. Shlomchik,et al.  Autoreactive B Cells Discriminate CpG-Rich and CpG-Poor DNA and This Response Is Modulated by IFN-α1 , 2008, The Journal of Immunology.

[17]  V. Pascual,et al.  The innate immune system in SLE: type I interferons and dendritic cells , 2008, Lupus.

[18]  F. Bazzoni,et al.  Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils. , 2008, Immunology letters.

[19]  I. Sanz,et al.  Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. , 2007, Arthritis and rheumatism.

[20]  S. Akira,et al.  Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. , 2007, Immunity.

[21]  J. Friedberg,et al.  B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny. , 2007, Clinical immunology.

[22]  F. Lund-Johansen,et al.  Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage. , 2006, Journal of molecular biology.

[23]  J. Browning.  B cells move to centre stage: novel opportunities for autoimmune disease treatment , 2006, Nature Reviews Drug Discovery.

[24]  D. Link,et al.  Activation of Tyk2 and Stat3 Is Required for the Apoptotic Actions of Interferon-β in Primary Pro-B Cells* , 2006, Journal of Biological Chemistry.

[25]  I. Maclennan,et al.  Stromal niches, plasma cell differentiation and survival. , 2006, Current opinion in immunology.

[26]  M. Cancro,et al.  Space, Selection, and Surveillance: Setting Boundaries with BLyS1 , 2006, The Journal of Immunology.

[27]  S. Tangye,et al.  Expansion of Functionally Immature Transitional B Cells Is Associated with Human-Immunodeficient States Characterized by Impaired Humoral Immunity1 , 2006, The Journal of Immunology.

[28]  S. Haeryfar.  The importance of being a pDC in antiviral immunity: the IFN mission versus Ag presentation? , 2005, Trends in immunology.

[29]  D. Golenbock,et al.  Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. , 2005, The Journal of clinical investigation.

[30]  P. Gregersen,et al.  The emerging role of interferon in human systemic lupus erythematosus. , 2004, Current opinion in immunology.

[31]  A. Cappione,et al.  Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. , 2004, Arthritis and rheumatism.

[32]  J. Kutok,et al.  TNF Family Member B Cell-Activating Factor (BAFF) Receptor-Dependent and -Independent Roles for BAFF in B Cell Physiology1 , 2004, The Journal of Immunology.

[33]  S. Akira,et al.  Toll-like Receptor 9–Dependent and –Independent Dendritic Cell Activation by Chromatin–Immunoglobulin G Complexes , 2004, The Journal of experimental medicine.

[34]  R. Boxio,et al.  Mouse Bone Marrow Contains Large Numbers of Functionally Competent Neutrophils , 2022 .

[35]  G. Kelsoe,et al.  Inflammation Controls B Lymphopoiesis by Regulating Chemokine CXCL12 Expression , 2004, The Journal of experimental medicine.

[36]  R Hal Scofield,et al.  Development of autoantibodies before the clinical onset of systemic lupus erythematosus. , 2003, The New England journal of medicine.

[37]  M. Nussenzweig,et al.  Predominant Autoantibody Production by Early Human B Cell Precursors , 2003, Science.

[38]  Virginia Pascual,et al.  Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. , 2003, Immunity.

[39]  Virginia Pascual,et al.  Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.

[40]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[41]  B. Nardelli,et al.  G-CSF–stimulated Neutrophils Are a Prominent Source of Functional BLyS , 2003, The Journal of experimental medicine.

[42]  J. Axford,et al.  Increased apoptosis of bone marrow CD34+ cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus , 2001, British journal of haematology.

[43]  J. Natvig,et al.  Bm1–Bm5 Classification of Peripheral Blood B Cells Reveals Circulating Germinal Center Founder Cells in Healthy Individuals and Disturbance in the B Cell Subpopulations in Patients with Primary Sjögren’s Syndrome1 , 2001, The Journal of Immunology.

[44]  P. Lipsky.  Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity , 2001, Nature Immunology.

[45]  L. Rönnblom,et al.  Presence of cutaneous interferon-a producing cells in patients with systemic lupus erythematosus , 2001, Lupus.

[46]  F. Lund-Johansen,et al.  Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. , 2001, The American journal of pathology.

[47]  J. Tschopp,et al.  Baff Mediates Survival of Peripheral Immature B Lymphocytes , 2000, The Journal of experimental medicine.

[48]  J. Cowland,et al.  Isolation of neutrophil precursors from bone marrow for biochemical and transcriptional analysis. , 1999, Journal of immunological methods.

[49]  J. Tschopp,et al.  Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations , 1999, The Journal of experimental medicine.

[50]  P. Sideras,et al.  B Cell Development in the Spleen Takes Place in Discrete Steps and Is Determined by the Quality of B Cell Receptor–Derived Signals , 1999, The Journal of experimental medicine.

[51]  M. Cooper,et al.  Impairment of  T and B Cell Development by Treatment with a Type I Interferon , 1998, The Journal of experimental medicine.

[52]  B. Garvy,et al.  Autoantibodies inhibit interleukin-7-mediated proliferation and are associated with the age-dependent loss of pre-B cells in autoimmune New Zealand Black Mice. , 1996, Blood.

[53]  M. Cooper,et al.  Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells. , 1995, Immunity.

[54]  G. Köhler,et al.  Transitional B cells are the target of negative selection in the B cell compartment , 1995, The Journal of experimental medicine.

[55]  J. Banchereau,et al.  Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. , 1995, Immunity.

[56]  J. D. Capra,et al.  Analysis of somatic mutation in five B cell subsets of human tonsil , 1994, The Journal of experimental medicine.

[57]  J. Liesveld,et al.  Cytokine regulation of early human lymphopoiesis. , 1994, Journal of immunology.

[58]  A. Notkins,et al.  Immune interferon in the circulation of patients with autoimmune disease. , 1979, The New England journal of medicine.

[59]  Yan Hu.  Isolation of human and mouse neutrophils ex vivo and in vitro. , 2012, Methods in molecular biology.

[60]  O. Donzé,et al.  APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa. , 2008, The Journal of clinical investigation.

[61]  F. Dammacco,et al.  Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18. , 2008, Arthritis and rheumatism.

[62]  J. Banchereau,et al.  IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice. , 2005, Journal of immunology.

[63]  S. Ikehara,et al.  Expansion of bone marrow IFN-alpha-producing dendritic cells in New Zealand Black (NZB) mice: high level expression of TLR9 and secretion of IFN-alpha in NZB bone marrow. , 2004, Journal of immunology.

[64]  L. Rönnblom,et al.  Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG. , 2003, Journal of immunology.

[65]  V. Pascual,et al.  Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. , 2001, Science.

[66]  U. Båve,et al.  The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer. , 2000, Journal of immunology.

[67]  K. Oberg,et al.  Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-alpha treatment. , 1991, Acta oncologica.

[68]  D. Perazzo,et al.  [Systemic lupus erythematosus]. , 1955, Prensa medica argentina.

[69]  Identification and characterization of circulating human transitional B cells , 2022 .